ANNUAL REPORT FY2006
Pharmacy Home Page | ( Complete report in .PDF format - 404kb )
Welcome
From the Department of Pharmacy Services | Inpatient
Drug Distribution Services | Clinical
Pharmacy Services
Ambulatory
Pharmacy Services | Medication
Safety | Drug
Information and Investigation Services
Research
and Education | HomeMed
Services | Computerization
and Automation
Continuous
Quality Improvement | Purchasing,
Inventory, Management, and Distribution | Business
Operations
MEDICATION SAFETY
John Mitchell, Pharm.D. Coordinator
The Institute of Medicine’s Report,
To Err is Human, followed by the 2006 report, Preventing Medication Errors,
highlights the advantages for having a dedicated individual who reviews each
medication incident and helps to maintain the integrity of the database that is
used to analyze and focus attention on important areas for improvement. The Medication Safety Coordinator for the
department focuses his attention on a variety of activities. Working in close collaboration with the Risk
Management Department, the coordinator reviewed nearly 2,400 reported
medication incidents in the past fiscal year.
Though most reports originate from the hospitals, medication incidents
are reported from throughout medical system, including offsite locations such
as our
·
Implementation
of PCA “smart pump” technology
·
Revision
and revision, as needed, of the hospital’s intrathecal
policy
·
Numerous
additions to our computerized dose-checking program
·
Inclusion
of standard indications for use on the MAR for those drugs which have a single
use indication
Throughout
the year, the Medication Safety Committee has worked closely with the
hospital’s computer team, which is charged with implementing computerized prescriber (CPOE) order entry before the end of 2006. Literature suggesting that CPOE potentially
could inject new errors into the healthcare process made this collaborative
effort a high priority to reduce that potential.
Medication Safety
Committee (MedSafe)
The Medication Safety Committee is a
multi-disciplinary group of clinicians who are dedicated toward improving the
safe use of medications throughout our healthcare environment. The committee is
represented by medical, pharmacy, and nursing staffs as well as members from
Risk Management, Quality Improvement, and HomeMed
(see membership list below). The
committee, which meets monthly, is advisory in nature and reports directly to
the hospital’s Pharmacy and Therapeutics Committee. MedSafe engaged in
a wide range of activities during the past fiscal year. Some of these include:
·
Selectively
reviewed a number of the 2391 medication safety incident reports submitted in
the past 12 months.
·
In
compliance with JCAHO revisions, UMHS changed its list of unapproved
abbreviations eliminating AU, AS, and AD.
·
Conducted
a thorough analysis of Ultravist contrast media
reactions; advised P&T to allow continued use of Ultravist
when it appeared that the number of serious adverse reactions trended downward
with less Emergency Department visit requirements.
·
Added a key member of the UM CareLink team to
the committee to help coordinate medication safety efforts with those being
considered for computerized order entry.
·
Supported
efforts during Pain Awareness Month by providing pens to staff imprinted with
the statement “Medication Safety: 1 mg Dilaudid = 10 mg morphine”.
·
Proposed
several changes to the Patient Care Orders Policy as a result of an event that
may have been precipitated by the use of homeopathic medication.
·
Approved
a list of standard PRN medications with single indications and requested
Pharmacy to add those indications to the instruction line of the MAR.
·
In
response to a JCAHO sentinel event review, changed the process for dispensing vincristine from a syringe to a 25-mL IVPB (except in
pediatric patients with fragile veins or who cannot cooperate during the slow
IVPB infusion).
Interdepartmental
Activities
Medication
Safety belongs to every member of the healthcare team who comes into contact
with our patients. Risk Management plays
a large role in providing a content-rich database for all reported patient
safety incidents, including medication safety reports. The medication safety coordinator meets with
members of the risk management team and nursing on a regular basis to discuss
both individual significant events and cumulative data that suggest trends
requiring the attention of MedSafe.
Patient
Safety Rounds are conducted bi-weekly and headed by the Office of Clinical
Affairs (OCA). These rounds provide an
avenue for staff members to voice issues and concerns regarding systems that
may subject a patient to errors. The
medication safety coordinator is a permanent member of this rounding team.
Serious
adverse events and sentinel events result in the activation of
multi-disciplinary teams that investigate the facts surrounding the event,
determine the root cause(s) of the event, and develop an action plan to
minimize the likelihood of the event reoccurring. This team is launched after a review by OCA
and usually includes physicians, pharmacists, nursing, risk management, and
quality improvement. Other disciplines
may be included as the event warrants.
Quarterly
reports are developed for the Continuous Quality Improvement Program Lead Team
in consultation with quality improvement, risk management, pharmacy, and
nursing.